Abstract
The return of COVID-19 symptoms after Nirmatrelvir/Ritonavir (Nm/R) treatment is being increasingly reported. Limited evidence suggests most cases of rebound symptoms are mild and do not require further intervention. Here we present a male veteran reporting rebound symptoms who was found to be hypoxic with pulmonary emboli. Our case highlights the need to evaluate known complications of SARS-CoV-2 including venous thromboembolism in patients reporting recurring symptoms. Further, cases of severe rebound phenomenon should continue to be reported by clinicians to better appreciate the use of the Nm/R during the Omicron wave and among vaccinated persons.
All Keywords
【저자키워드】 SARS-CoV-2, Paxlovid, Paxlovid rebound, COVID-19: Pulmonary embolism, 【초록키워드】 Treatment, Intervention, Symptom, omicron, Venous Thromboembolism, Symptoms, male, Patient, Complication, Mild, Evidence, COVID-19 symptom, Pulmonary emboli, clinician, highlight, hypoxic, evaluate, reported, increasingly, Limited, 【제목키워드】 Pulmonary emboli, treatment for COVID-19,
【저자키워드】 SARS-CoV-2, Paxlovid, Paxlovid rebound, COVID-19: Pulmonary embolism, 【초록키워드】 Treatment, Intervention, Symptom, omicron, Venous Thromboembolism, Symptoms, male, Patient, Complication, Mild, Evidence, COVID-19 symptom, Pulmonary emboli, clinician, highlight, hypoxic, evaluate, reported, increasingly, Limited, 【제목키워드】 Pulmonary emboli, treatment for COVID-19,